RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
about
Novel Insights into the Roles of Rho Kinase in CancerRegulation of ROCK activity in cancerPathophysiological Functions of Rnd3/RhoERhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of CXCR4.Rnd3 regulates lung cancer cell proliferation through notch signalingRnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure.miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoEmiR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1FKnock-Down of Endogenous Bornavirus-Like Nucleoprotein 1 Inhibits Cell Growth and Induces Apoptosis in Human Oligodendroglia Cells.The RhoE/ROCK/ARHGAP25 signaling pathway controls cell invasion by inhibition of Rac activity.Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.Rho'ing in and out of cells: viral interactions with Rho GTPase signalingRh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.Rho GTPases and cancer.RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.Genetic deletion of Rnd3 in neural stem cells promotes proliferation via upregulation of Notch signaling.MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.Analysis of expression profile data identifies key genes and pathways in hepatocellular carcinoma.MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
P2860
Q26771368-1FF1781A-79FA-42B3-83FF-C9D45D291E4EQ27006554-9278436B-D349-437C-90FE-3D7DA4CAF550Q28078292-81ED2C24-8316-4B29-BD71-826EA9527727Q35060652-C5A68E29-6834-4569-B7BD-52791EC52117Q35394876-F6F98431-FDA5-44AE-8DDC-15E6E3732005Q36179543-793AE9BC-3B6F-4C0C-BD01-719D347998D8Q36502836-AD300E1E-455F-4360-8395-18F5C4C4370CQ36545884-1B4F0E69-EEED-4437-AD27-C487AE078A86Q36846859-C8414942-3C5C-4F23-AA3A-8DD8A24B9048Q37222533-3F856260-381E-4B5A-9AB8-1DDC877EBB3AQ37357410-E3760250-F75D-4DD6-919B-C8B5882F1EB8Q37562328-8AF02C19-B0C8-43AD-9EDF-073A584290C7Q38201237-7A51CD5F-2DA7-429A-ACAF-D287EC3437C5Q38800502-9A3E78D1-3AAE-4FEA-A73B-C26581610FAEQ38982148-BB119A6F-0B05-495F-8FDC-1C5DC0B55CC8Q39283279-F05407B3-9193-448E-BFB1-2A04FBB4FB79Q39541068-BDA45346-61A8-4A3F-94AB-C89562322825Q47095439-BD0971CF-0E7B-4289-9479-C49E7A14DB7DQ49183912-787908DD-03B3-493E-A90A-DF610920E27CQ50053438-84AFB5A8-FFDD-4967-AE29-A62C72C3086AQ52899937-E12D1246-3E34-4613-AD92-D6F11275F028
P2860
RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
RhoE is frequently down-regula ...... in phosphatase target pathway.
@en
RhoE is frequently down-regulated in hepatocellular carcinoma
@nl
type
label
RhoE is frequently down-regula ...... in phosphatase target pathway.
@en
RhoE is frequently down-regulated in hepatocellular carcinoma
@nl
prefLabel
RhoE is frequently down-regula ...... in phosphatase target pathway.
@en
RhoE is frequently down-regulated in hepatocellular carcinoma
@nl
P2093
P2860
P356
P1433
P1476
RhoE is frequently down-regula ...... sin phosphatase target pathway
@en
P2093
Carmen Chak-Lui Wong
Chun Ming Wong
Edmund Kwok-Kwan Tung
P2860
P304
P356
10.1002/HEP.25987
P407
P50
P577
2013-01-01T00:00:00Z